89%
Finnrick rating
#8 of 233 Retatrutide vendors
16 of 17 classifiable tests passed
natural 94% · customers 4.9★ (25)
methodology · Purity focus
Finnrick analysis · Retatrutide

Orbitrex Peptides retatrutide is held back by an early 99.2% purity miss; later results show identity passes, ≥99.8–99.9% purity, and fills inside tolerance despite one +20% overfill. Batch-source gaps include a no-ID May result.

methodology →
vendor intelligence report
Vendor Intelligence Report: Orbitrex Peptides

We investigated who actually operates Orbitrex Peptides — corporate records, ownership trails, web infrastructure, and how its lab results break down product by product. Read the full report before you order.

21 pages6 risk factors assessed13 Jun 2026
read the report
Peptides
#
Peptide
$/MG
Rating
N
1
GHK-Cu
$0.80
91%
5
2
Retatrutideselected
$8.00
89%
18
3
Tirzepatide
$5.00
79%
5
4
PT-141
-
70%
2
Contact channels
Rating trend
CUMULATIVE FINNRICK RATING
83%+65%+48%+30%+<30%23 Oct 2025: 72%23 Oct 2025: 74%23 Nov 2025: 75%23 Nov 2025: 77%13 Feb 2026: 80%2 Mar 2026: 81%4 Mar 2026: 82%18 Mar 2026: 84%25 Mar 2026: 85%23 Apr 2026: 86%28 Apr 2026: 87%28 Apr 2026: 87%28 May 2026: 88%2 Jun 2026: 89%12 Jun 2026: 89%25 Jul 2026: current 89%72%80%89%Oct 25Jul 26
Showing Retatrutide tests only
Orbitrex Peptides Retatrutide test history
COA-backed lab tests
DateResultTestLabPurityDosageLabelCOA
12 Jun 2026Pass
Tested
lab nameView COA
2 Jun 2026Pass
Tested
lab nameView COA
28 May 2026Pass
Tested
lab nameView COA
28 Apr 2026Pass
Tested
lab nameView COA
28 Apr 2026Pass
Tested
lab nameView COA
23 Apr 2026Pass
Tested
lab nameView COA
25 Mar 2026Pass
Tested
lab nameView COA
18 Mar 2026Pass
Tested
lab nameView COA
4 Mar 2026Pass
Tested
lab nameView COA
2 Mar 2026Pass
Tested
lab nameView COA
1-10 of 18

About Orbitrex Peptides test results from Finnrick

Orbitrex Peptides is a peptide vendor tracked in Finnrick's independent testing dataset. This page compiles batch-level results across 4 peptides and 30 tests, including ratings, observed price signals, recent test dates, and correction history where available.

Finnrick ratings are calculated from published sample data using the selected rating standard. The default standard evaluates purity, dose accuracy, and label quality, then adjusts low-volume results so small sample counts do not appear more certain than the data supports.

The most visible Orbitrex Peptides peptides in this dataset are Retatrutide (18 tests). Use the peptide table above to compare the current Finnrick rating, price per mg, and sample volume for each peptide.

Recent tests and corrections are shown below when available. Samples may be acquired by Finnrick directly or submitted through Finnrick testing programs; the goal is to make safety and supply-chain evidence easier to evaluate than vendor marketing claims alone. This page currently lists 30 recent tests.

Corrections
No corrections.